1
CURRICULUM VITAE
OF
DAVID GORDON, MD
2014-2015
Rank:
Professor
Area of Responsibility:
Dean, College of Health Professions, University of Akron
Date of Initial Appointment:
October 31, 2014
Date of Appointment to Current Rank:
October 31, 2014
License Numbers:
1980 Washington
1992 Michigan
Certifications:
Board 1985 Anatomic Pathology
Graduate Faculty Status:
Pending
EDUCATION
Sept. 1967- June 1969
June 1969 – Sept. 1969
Sept. 1969- May 1973
May 1973-Sept 1973
Sept. 1973- June 1979
Northwood High School, Silver Spring, MD
Summer employment (Mrs. Kay’s Toll House, Silver Spring, MD)
Amherst College, Amherst, MA, A.B. (summa cum laude)
Summer employment (Natl. Oceanic Atmospheric Admin., Silver Spring, MD)
Harvard Medical School, Boston, MA, M.D. (cum laude)
POSTDOCTORAL TRAINING & FELLOWSHIPS
Dec. 1, 1977- Nov. 30, 1979
Medical Student Research Fellowship with Morris J. Karnovsky, Harvard
Medical School, Boston, MA (Vessel wall biology in rat models of intimal
thickening)
July 1, 1979- June 29, 1980
Internship in Internal Medicine, University of Massachusetts Medical Center,
Worchester, MA
July 1, 1980- Mar. 1985
Residency in Pathology, University of Washington School of Medicine, Seattle,
WA
July 1, 1981-June 30, 1984
Postdoctoral Research Fellowship, Department of Pathology, University of
Washington School of Medicine, Seattle, WA
1
2
EXECUTIVE EDUCATION (Courses/Seminars)
2000
Univ. of Michigan Business School Executive Education Center: “Fundamentals of
Leadership.”
2002
Harvard Univ. Program on Negotiation: “Teaching Negotiation in the Organization”
April 7-9.
Essentials for Leading a Diverse Workforce (diversity training course given by UMHS
Human Resources. I also served as a facilitator for other such courses)
2003
2004-2005
Univ. of Michigan Health System Leadership Development Program
2004, 2008
AAMC Executive Development Seminar for Associate Deans and Dept. Chairs.
2006
The Masters Series Leadership Course (given by UMHS Human Resources June 12-16,
2006)
ACADEMIC APPOINTMENTS
Mar. 1, 1985- July 1, 1991
Assistant Professor of Pathology, Department of Pathology, University of
Washington School of Medicine, Seattle, WA
July 1, 1991- Nov. 15, 1991
Associate Professor of Pathology (with tenure), Department of Pathology, University
of Washington School of Medicine, Seattle, WA
Dec. 1, 1991-Nov. 16, 1997
Associate Professor of Pathology, Department of Pathology, University of Michigan
School of Medicine, Ann Arbor, MI (Received tenure 1997)
Nov. 16, 1997- Jan. 31, 2001 Adjunct Associate Professor of Pathology, Department of Pathology, University of
Michigan School of Medicine, Ann Arbor, MI (Note: during this time I was a
research fellow with Pfizer Global Research and Development, Ann Arbor, MI.)
Feb. 1, 2001- Oct. 31, 2014
Oct. 31, 2014 – present
Professor of Pathology (with tenure), Dept. of Pathology, Univ. of Michigan School
of Medicine, Ann Arbor, MI
Professor (Active Emeritus) of Pathology (with tenure), Dept. of Pathology, Univ. of
Michigan School of Medicine, Ann Arbor, MI
OTHER WORK EXPERIENCE:
Nov. 16, 1997- Jan. 31, 2001 Research Fellow, Pfizer Global Research and Development (Preclinical
Cardiovascular Division), Ann Arbor, MI. Note: My employment here was
originally with Parke-Davis Inc. which was later taken over by Pfizer Inc.
2
3
ACADEMIC ADMINISTRATIVE APPOINTMENTS
Mar. 1, 1985- Nov. 15, 1991 Director of Autopsy Service, Univ. of Washington, Univ. Hospital
Aug. 1, 1994 - Nov. 16, 1997 Assistant Dean for Faculty Affairs, University of Michigan, Ann Arbor, MI.
July 1, 1996- Nov. 16, 1997 Associate Director, Jobst Vascular Research Laboratory, Div. of Vascular Surgery,
University of Michigan, Ann Arbor, MI
Feb.1, 2001 - Mar. 31, 2004 Assistant Dean for Diversity and Career Development. University of Michigan, Ann
Arbor, MI
April 1, 2004-2011
Associate Dean for Diversity and Career Development, University of Michigan, Ann
Arbor, MI
Aug. 16, 2011- Oct. 31, 2014 Dean, School of Health Professions and Studies, University of Michigan-Flint, Flint,
MI
Oct. 31, 2014 – present
Dean, College of Health Professions, University of Akron, Akron, Ohio
DEAN’S OFFICE RELATED DUTIES:
2001-2011
2002-2011
2002- 2011
2002-2011
2002-2009
2003-2011
20002-2011
2004
2005
2004-2009
2005
2005
2005-2006
2006
2006-2011
2006-2011
2006-2011
2006-2007
2007
2007-2009
2007-2009
2007-2011
2009-2011
2009-2010
Medical School Admissions Executive Committee
Director: Medical School Diversity and Career Development Office
Director: Minority Health Research Program
Member: Univ. of Michigan Health System Diversity Advisory Team Steering
Committee
Director, Health Occupations Partners in Education (HOPE) program (a health
professions schools program mentoring Ypsilanti middle and high school students
towards the health professions).
Member: Univ. of Michigan Diversity Council (Chair December 2004 – June 2007)
Member Univ. of Michigan Medical School K30/K12 Clinical Research Training Grant
Advisory Board.
Participant Univ. of Michigan Provost seminar and workshop: Transformative Pedagogy
in a Contested World
Multicultural Pedagogy Workshop Participant (May 23, 2005)
Member: Univ. of Michigan National Center for Institutional Diversity Steering
Committee and regular committee.
Planner, moderator and participant: Futuring Diversity Conference (May 17-18, 2005)
Member: Search Committee for new head of Organizational Effectiveness, UMHS
Human Resources
Member: Search Committee for new CEO of University of Michigan Hospital and Health
Services.
Member: Search Committee for new Assoc. Dean for Student Programs (U. of M.)
Member Univ. of Michigan Health System Leadership Advisory Group
Member of the Leadership Competencies Subcommittee (Leadership Advisory Group)
Co-chair of the Succession Planning Subcommittee (Leadership Advisory Group)
Member and functional chair of the Medical School Taskforce on Team
Science/Scholarship
Member, Univ. of Michigan Diversity Blueprints Taskforce
Member, Community Health Initiative Committee (Faculty Group Practice subcommittee to look at community benefits from our Health System).
Member, Univ. of Michigan Health System Community Benefits Report Committee
Medical School Lead for Faculty and Staff Leadership Development Programs.
Member, Michigan Institute for Clinical and Health Research (MICHR) Education
Admissions Committee
Vice-Chair, Univ. of Michigan Human Resources Advisory Group
3
4
2010-2011
2011-2014
2011- 2014
2012-2014
2012-2014
2012-2014
2012
2012-2014
2013-2014
2013-2014
2014
2014 – present
Chair, Univ. of Michigan Human Resources Advisory Group
Member, Greater Flint Health Coalition Board of Directors
Member Michigan Health Council (non-voting member 2011-2014, voting member of
their Board of Trustees, 2014
Member, Genesee Health Plan Board of Directors
Member, Universal Kidney Foundation Advisory Board
Member, Univ. of Michigan MHealthy Advisory Board
Michigan State University’s College of Human Medicine’s Milestones Curriculum
Project (designing a new curriculum for Flint students)
Attendee of the Ann Arbor Veterans Administration Hospital’s Affiliation Partnership
Council
Attendee of the Saginaw Veterans Administration Hospital’s Academic Affiliation
Committee
Director, University of Michigan-Flint Social Justice Center (planning)
Member, Board of Directors for the Hamilton Community Health Network (a Federally
Qualified Health Center in Flint, Michigan)
Member, Institute for Healthcare Improvement (IHI) Leadership Alliance of Akron
COMMUNITY SERVICE/VOLUNTEERING
2012-2013
2013
Participant, Leadership Genesee Program (Community orientation to Genesee County)
Volunteer, Hamilton Community Health Network (Federally Qualified Health Center in
Flint)
CLINICAL/HOSPITAL APPOINTMENTS
1985-91
1992-present
1991- 2011
Staff physician, University of Washington School of Medicine, Seattle, WA.
Staff physician, University of Michigan Health System, Dept. of Pathology, Ann Arbor,
MI.
Member, Cardiovascular Research Institute, University of Michigan, Ann Arbor, MI
CONSULTING POSITIONS
1987-1990
1990
1991-1997
1995
2001-2002
Cardiovascular pathology consultant for Genentech, Inc., San Francisco, CA
Cardiovascular pathology consultant for Lilly Research Laboratories, Indianapolis, IN
Cardiovascular pathology consultant for Parke-Davis Inc., Ann Arbor, MI
Consultant for Gladstone Institute of Cardiovascular Disease, San Francisco, CA
Consultant for GenVec Inc. (gene therapy biotechnology company).
SCIENTIFIC POSITIONS IN INDUSTRY
i)
1997-2001 Research Fellow, Department of Vascular and Cardiac Diseases, Parke-Davis
Pharmaceutical Research, Ann Arbor, MI (became part of Pfizer, Inc.). Note: Led a therapeutic
angiogenesis discovery team to identify adenoviral mediated gene transfer methods to grow new blood
vessels for people with coronary and peripheral vascular disease.
4
5
SCIENTIFIC ACTIVITIES
Grant Review Committees
1989
1990
1991
1992
1992-1995
1992-1995
1993-1995
1994
1994
1995-1998
2005
Ad Hoc American Heart Association of Los Angeles, CA
NHLBI Ad Hoc Special Review of Wissler PDAY Renewal
NHLBI Ad Hoc Review Committee, Duke University Prog. Proj.
NHLBI Ad Hoc Review Committee, New England Deaconess, Boston, MA
American Heart Association (National) (Grant-In-Aid Committee)
American Heart Association (National) (Fellowship Committee)
American Heart Association of Michigan (Grant-In-Aid Committee)
NIH Minority Fellowship Review Committee (NHLBI)
Ad hoc reviewer for NIH Pathology A Study Section.
Member NIH Pathology A Study Section
Ad hoc reviewer for NIH Hemostasis & Thrombosis Study Section
Other National Committees:
2001-2005
National Academy of Sciences Committee for “Assessment for NIH Minority Research
Training Programs Phase 3”
GRANT SUPPORT
Past:
1122.RFP.PD
09/01/06 to 08/31/09
$48,735/year direct costs.
No-cost time extension 09/01/09 to 12/31/09
Renewed funding at $35K/year, 1/1/10 – 12/30/11
Blue Cross Blue Shield of Michigan Foundation (D. Gordon, PI 2006-2010, and co-PI
2010-present, 5% effort):
“Encouraging Physicians to Practice in Underserved Communities: Medical School
Rotation Strategy”
NIH PO1 HL57346 “Molecular Genetics Coagulation Disorders” 4/1/09 – 3/31/14 PI: D.
Ginsburg
Morphology Core Director: D. Gordon (5%); Direct costs ($74,878/year)
UL1 RR024986 (K. Pienta, PI)
09/17/2007 – 05/31/2012
KL2 RR024987 (Mentored Career Development Component)
TL1 RR024988 (Predoctoral Training Grant Component)
NIH / NCRR
$54,619,564 total direct cost
Michigan Institute for Clinical and Health Research (MICHR); CTSA grant
D. Gordon: co-Director, Community Engagement Component (5% effort)
HRSA 1D18HP13634 0100:
9/1/2009 to 8/31/2012
Department of-Health Resources and Services Administration (HRSA) HCOP grant: “An
Interdisciplinary Approach to Enhancing Access to Health Care” PI: M. Woolfolk; Co-I:
D. Gordon. This is a summer academic enrichment program run by the Univ. of
Michigan Schools of Dentistry and Medicine and which mentors underrepresented
minority and socioeconomically disadvantaged undergraduate students towards dental
and medical school. $384,637.00 total annual direct cost.
Project Director, National Institute of Health (HL-03174), “The Biochemistry of Vascular
Smooth Muscle Cell Differentiation and Proliferation,” Earl P. Benditt, P.I. 3/1/85 2/29/88, ($58,870/yr).
5
6
Robert Wood Johnson Foundation Fellowship (10870), “Smooth Muscle Cell
Differentiation” 1/1/85 - 12/31/88 ($58,678/yr).
Project Director, Grant-in-Aid from The National American Heart Association and its
Washington State Affiliate (88-0916), “Cell Proliferation in the Human Artery Wall”,
7/1/88 - 6/30/91 ($28,000/yr).
Principal Investigator, National Institute of Health, (HL-42119-01), “Proliferation and
Growth Factors in Atherosclerosis”, 12/1/88 - 11/30/93
($120,264/yr)
National Institute of Health, (RO1 HL-43322-01), “Cells and Molecules Mediating Graft
Atherosclerosis” S. Coughlin, P.I.; D. Gordon, P.I. for Seattle subcontract 7/1/89 4/30/94, ($50,134/yr).
(P50 HL-42770 SCOR), “Vascular Disease” D.E. Strandness, P.I.; Morphology Core B:
D. Gordon, Director, 1/1/90 - 12/1/91, ($146,294/yr).
Michigan American Heart Assoc. Grant-in-Aid: “The Patterns of Collagen Synthesis
During Arterial Restenosis” D. Gordon, P.I., 7/1/93 - 6/30/94, ($27,000).
Michigan Diabetes Research and Training Center Pilot/Feasibility Grant: “Cell
proliferation and collagen gene expression in human diabetic atherosclerosis ” D.
Gordon, P.I., 12/1/94 - 11/30/95, ($24,000/yr).
National American Heart Assoc. Grant-in-Aid: “Vascular Biology Patterns of Collagen
Gene Expression in Human Atherosclerosis” D. Gordon, P.I., 7/1/93 - 6/30/96,
($40,000/yr).
American Heart Assoc. of Michigan: “A Gene Therapy Approach to Transplant
Arteriosclerosis” D. Gordon, P.I., 7/1/95 - 6/30/97, ($28,000/yr).
Taisho Excellence in Research Program Grant: “The Fibrogenic Intimal Cell of
Atherosclerosis” D. Gordon, P.I., 12/1/95 - 11/30/98, ($70,000/yr).
National Institutes of Health, NIH DK42706: “Expression of recombinant TGF-beta in
arteries” E.G. Nabel, P.I.; D. Gordon, Co-Investigator, 8/1/93 - 7/31/98
($161,341/yr).
National Institutes of Health, NIH-NIAID AI36606: “Molecular Genetic Interventions for
Pediatric AIDS” G.J. Nabel, P.I.; D. Gordon, Co-director of Morphology Core, 8/1/94 7/31/98, ($115,911/yr).
NIH-NHLBI HL53466: “Gene Transfer into the Pulmonary Vasculature” E.G. Nabel,
P.I.; D. Gordon, Co-Investigator, 12/1/94 - 11/30/98, ($170,314/yr direct costs).
Civilian Research & Development Foundation, CRDF Award #RN1-416: “The role of
angiogenesis in human atherosclerosis.” D. Gordon, U.S. P.I.; A. Orekhov, Russian P.I.
(collaborative grant) 10/1/97 - 9/30/99, ($35,000/2 years direct costs).
(NOTE: This grant was given up when I became employed at Parke-Davis
Pharmaceutical Research, which is a “for profit” institution.)
Association of American Medical Colleges, Health Professions Partnership Initiative:
“Health Occupations Partners in Education” (HOPE) D. Gordon, P.I.
7/1/98 - 6/30/03, ($70,000/yr direct costs).
6
7
(NOTE: This is a grant out of the Univ. of Michigan Medical School's Dean's office. I
relinquished the position of principal investigator as a result of employment at ParkeDavis Pharmaceutical Research, although Parke-Davis is a formal partner in this grant
funded effort.)
National Institutes of Health, (HL-42119-01): “Cell growth and collagen synthesis in
atherosclerosis” D. Gordon, P.I., 4/1/95 - 3/31/98 with no-cost extension until March,
1999, ($148,810/yr).
Kellogg Foundation: “Kellogg Michigan Consortium for Minority Health and
Development” D. Gordon PI; 2/1/03 – 1/31/04 ($100,000)
M01-RR00042 (R. Kelch) Gen. Clin. Research Center3/01/2006 – 9/17/2007
NIH National Center for Research Resources
$5.8 Million
D. Gordon: Director of the Minority Health Research Program (5%)
NIH PO1 HL57346 “Molecular Genetics Coagulation Disorders” 7/1/03 – 6-30-08 PI:
D. Ginsburg
Morphology Core Director: D. Gordon (10%); Direct costs ($99,717/year)
Howard Hughes Medical Institute: Health Occupations Partners in Education (HOPE)
(HHMI Precollege Science Education Initiative): D. Gordon PI; 9/1/03 – 8/31/08
($538,574) With a no-cost time extension until August 30, 2009.
Community Foundation of Greater Flint: “Telemedicine Outreach for Underserved
Populations” D. Gordon: PI, March 2013 – Feb. 2014
CERTIFICATION AND LICENSURE
Board
1985
Anatomic Pathology
License
1980
1992
Washington
Michigan
MILITARY SERVICE
None
HONORS AND AWARDS
1973
1979
2004
2004
2009
Phi Beta Kappa; summa cum laude Sigma Xi (Amherst College)
cum laude (Harvard Medical School)
Univ. of Michigan Harold R. Johnson Diversity Service Award
2003-2004 Medical Student Award for Teaching Excellence (for pathology laboratory
instructors)
National Center for Institutional Diversity Exemplary Diversity Engagement and
Scholarship Award
7
8
MEMBERSHIPS AND OFFICES IN PROFESSIONAL SOCIETIES
Society for Cardiovascular Pathology
Councilor 1992-1995,
Member 2000-2010
National Medical Association 2003-2011
Association of American Medical Colleges 2001- 2011
Univ. of Michigan representative for the Minority Affairs Section (Group on Student Affairs—GSAMAS) 2001-2009
Univ. of Michigan representative for the Group on Diversity and Inclusion, 2009- 2011
American Society for Investigative Pathology
Membership and Program Committees 1992-1996
Membership 1997-2011
Minisymposium Chair, 1996 Exp. Biol. Meeting
International Society for Heart Transplantation
U.S. and Canadian Academy of Pathology, Inc.
Arteriosclerosis Council, American Heart Association
Abstract reviewer for National Meeting, 1995
North American Vascular Biology Organization 1995 - 2010
American Heart Association, Michigan Affiliate Program Committee, 1994-2000
JOURNAL EDITORIAL BOARDS
Cardiovascular Pathology
TEACHING ACTIVITIES
University of Washington
1985-1991
1985-1989
1985-1990
1987-1991
1990-1991
1985-1991
1989-1991
1985-1991
Lecturer in HuBio 520 course (“Tissue Reaction to Injury”)
Laboratory Section leader for Introduction to Pathology Course for first year medical
students (HuBio 520; 6-8 contact hours per year)
Lecturer for Pathology Residents Seminar series (one contact hour) on infarct dating
Lecturer in Introduction to Pathology Course for first year medical students (HuBio 520;
3 contact hours yearly since 1987) on atherosclerosis and myocardial infarction
Lecturer in Introduction to Pathology Course for non-medical students (Pathology 410;
two contact hours per year) on atherosclerosis and myocardial infarction
Director of weekly Autopsy Conference and Medicine/Pathology Correlation Conference
(one hour weekly)
Presenter of pathology at monthly thoracic surgery Morbidity and Mortality Conference
Give monthly talks about Pathology to visiting high school and college students
(particularly minority groups) (1/2 contact hour)
University of Michigan
1993-present
1994-1997
1993-1995
1995-present
2001- present
Lecturer Cardiovascular Sequence for 2nd year medical students.
Chair of Vascular Biology Journal Club
Laboratory Instructor Pathology 600 Systemic Pathology
Laboratory Instructor Pathology (for 2nd year organ systems courses for medical
students)
Lecturer Pathology Course for Dental Students (cardiovascular pathology lectures).
8
9
2005- 2011
Lecturer in Dept. of Pathology general pathology course for graduate students (Path 581).
Graduate student and Postdoctoral fellows (training/mentoring)
1990-1991
F. Frank Isik, M.D. Frank is currently Asst. Prof. Plastic Surgery, Univ. of Washington,
Seattle.
1991-1995
Mark D. Rekhter, M.D., Ph.D. Mark is currently a Senior Scientist at Pfizer, Ann
Arbor.
1996-1997
Sergey Filippov, M.D. Sergey is currently a Research Associate, Dept. of Internal
Medicine, Univ. of Michigan (Stephen Weiss Laboratory)
1997-1999
Yunling Song, M.D.
Yunling is currently a scientist at Pfizer, Ann Arbor Indirect
Postdoctoral Fellows (officially in other labs, but mentored by me)
1993-1995
Vincent J. Pompili, M.D. Vince was in the laboratory of Elizabeth Nabel in Cardiology.
He is now an Assistant Prof. At the Cleveland Clinic in Cardiology.
1995-1997
Raj Sarkar, M.D., Ph.D. Raj was working with R. Clinton Webb in Physiology, and is
currently an Asst. Prof. At Univ. of California San Francisco (Vascular Surgery).
1994-1996
Robert Simari, M.D. Rob was working in the laboratory of Elizabeth Nabel in
Cardiology. He is now an Asst. Prof. at Mayo Clinic in Cardiology.
1997-2009
He Wang, M.D., Ph.D. He was a postdoctoral fellow with Joan Keiser at Pfizer, but was
assigned to my laboratory, and did research under my direction. As of July 1, 2006 a
resident in our Univ. of Michigan Dept. of Pathology.
1998-2000
AtaçTürkay, M.D. I was on his Ph.D. thesis committee (Human Genetics). He took a
faculty position at a different institution (Chicago).
2004-2006
Brenda Sun Yong Cho (thesis committee). Research mentor is Gilbert Upchurch (Dept.
of Surgery) and research focus is aneurysm biology.
EXTRAMURAL INVITED RESEARCH PRESENTATIONS
“Growth factors and cell proliferation in human atherosclerosis.” Alexis Carrel Conference on Transplant
Arteriosclerosis, 1989.
“Cell proliferation in human coronary and carotid arteries.” Altschul Conference on Arteriosclerosis,
Saskatoon, Canada, 1989.
“Cell proliferation in human coronary arteries.” The Lofland Conference on Arteriosclerosis, San Antonio,
Texas, 1990.
“Growth factors and cell proliferation in human atherosclerosis. ” Lilly Corp., Indianapolis, IN, 1990.
“Cell proliferation in human transplant coronary arteries.” The International Academy of Pathology,
Chicago, IL, 1991.
“Cell proliferation in human atherosclerosis.” The Department of Pathology, University of Michigan, Ann
Arbor, MI, 1991.
“Cell proliferation in the coronary arteries of transplanted hearts.” The Blood Vessel Club,” FASEB
Meeting, Atlanta, GA, 1991.
“Cell proliferation in transplant arteriosclerosis.” St. Louis University, October 25, 1991.
“Cell proliferation in human arteries.” The U.S. and Canadian Academy of Pathology, Atlanta, GA, 1992.
“Cell proliferation in human arterio-venous dialysis shunts.” The “Blood Vessel Club,” FASEB Meeting,
Anaheim, CA , 1992.
9
10
“Cell proliferation in human atherosclerosis.” Tufts University, Division of Cardiology, Boston, MA,
1992.
“Cell proliferation in human atherosclerosis.” Krannert Institute of Cardiology, Indianapolis, IN, 1992.
“Cell Proliferation and Collagen Gene Expression in Human Atherosclerosis.” Talk at Univ. of Virginia
(Department of Physiology), June 30, 1992.
“Cell Proliferation and Collagen Gene Expression in Human Atherosclerosis.” Pediatric Cardiology
Division, Univ. of Michigan, Feb. 2, 1994.
“Cell Proliferation and Collagen Gene Expression in Human Atherosclerosis.” Cleveland Clinic
Department of Vascular Biology, Feb. 18, 1994.
“Cell Proliferation and Collagen Gene Expression in Human Atherosclerosis.” Department of Pathology,
Univ. of Michigan, Feb. 23, 1994.
“Cell Proliferation and Collagen Gene Expression in Human Atherosclerosis.” Society for Biomaterials
conference held in Boston, MA, April 5, 1994.
“Cell Proliferation and Collagen Gene Expression in Human Atherosclerosis.” Vascular Medicine Seminar
Series, Univ. of Michigan, May 3, 1994.
“Cell Proliferation and Collagen Gene Expression in Human Atherosclerosis.” Talk given to Department of
Pathology, Univ. of Toronto, Canada; May 4, 1994.
“Cell Proliferation and Collagen Gene Expression in Human Atherosclerosis.” American College of
Veterinary Pathologists meeting in Toronto, Nov. 3, 1994.
“Growth factors as inducers of neointimal hyperplasia.” Special symposium on “Transplant Vascular
Sclerosis” sponsored by Ohio State University College of Medicine, held in Bermuda, Feb. 2, 1995.
“Cell Proliferation and Collagen Gene Expression in Human Atherosclerosis.” Univ. of Michigan to
Cardiology (Grand Rounds), June 6, 1995.
“Cell Proliferation and Collagen Gene Expression in Human Atherosclerosis.” Talk given at Univ. of
Michigan to Gene Therapy Group (seminar series), June 8, 1995.
“Cell Proliferation and Collagen Gene Expression in Human Atherosclerosis.” Talk given to Gladstone
Institute of Cardiovascular Disease (San Francisco), July 24, 1995.
“Cell Proliferation and Collagen Gene Expression in Human Atherosclerosis.” Talk given to Texas
Biotech. Inst. (Houston, TX) Oct. 13, 1995.
“Cell Proliferation and Collagen Gene Expression in Human Atherosclerosis.” Talk given to Vascular
Medicine Program, Univ. of Michigan, Feb. 6, 1996.
“Cell Proliferation and Collagen Gene Expression in Human Atherosclerosis.” Talk given to Department of
Surgery, at Univ. of Arizona (Tucson), Mar. 8, 1996.
“The growth of human atherosclerosis: Cell proliferation and collagen synthesis.” U.S. and Canadian
Association of Pathologists meeting (Society for Cardiovascular Pathology) Mar. 24, 1996; Washington
D.C.
10
11
“Cell proliferation and collagen synthesis in human atherosclerosis.” Talk given to Genentech Inc. (San
Francisco, CA) Sept. 4, 1996.
“Restenosis: A Pathologist’s view.” Restenosis Summit, Cleveland, Ohio 1997.
“Cell proliferation and collagen synthesis in human atherosclerosis.” Talk given to Cardiology Division,
Univ. of Michigan, April 3, 1998.
“Growth of human atherosclerosis.” Talk given at the 9th Annual R.W. Gunton Symposium on
Cardiovascular Therapeutics, sponsored by the John P. Robarts Research Institute and presented at the
University of Western Ontario, Canada (September. 11, 1998).
“The cellular growth of human atherosclerosis.” Talk given to the Midwestern Vascular Surgical Society
meeting in Chicago, Sept. 25, 1999.
“Growth factors, cell proliferation and collagen synthesis in human atherosclerosis.” Talk given to the
U.S.-Italy Joint Symposium on Genetic and Pharmacological Approaches in Vascular Biology, at the
University of Milan, Italy (Dec. 2-4, 1999, sponsored by the National Institutes of Health, and the Institute
of Pharmacological Sciences at the University of Milan).
“Atherosclerosis in African Americans: Path Prevention and Treatment.” Ernest E. Just Symposium at
Medical University of South Carolina, Feb. 14, 2003
OTHER INVITED DEAN’S OFFICE PRESENTATIONS
“Diversity in Medical Education” Presentation to the Medical Educators Scholars Program, Univ. of
Michigan, June 17, 2003
“Diversity in Medical Education” Presentation to the Medical Educators Scholars Program, Univ. of
Michigan, May 11, 2004
“Visible and Invisible Aspects of Diversity” Presentation to Dept. of Pathology faculty and staff, May 11,
2005.
“Life after the Supreme Court: How the University of Michigan maintained their minority medical school
enrollment.” Keynote talk at the national American Medical Association meeting (Minority Affairs
Caucus), Chicago June 17, 2005.
“HPPI Sustaining Funding: The Story of our Univ. of Michigan HOPE Program.” Talk given at the Assoc.
of American Medical Colleges’ Health Professionals Partnership Initiative last meeting, Wash. DC, Oct. 2,
2005.
“Role of Development in Funding Outreach Clinics and Other Special Projects: Thoughts on Obtaining
External Funding.” Talk given at the Assoc. of American Medical Collages GSA-MAS national meeting in
Philadelphia, April 4, 2006.
"Rock the Match: strengthening your ERAS application” Talk to medical students at the annual Student
National Medical Association, New York, March 21, 2008.
"Addressing Diversity in Graduate Medical Education: Challenges and Perspectives" Panel discussion at
the annual Association of American Medical Colleges meeting, San Antonio, Texas; Nov. 4, 2008
11
12
"Rock the Match: strengthening your ERAS application” Talk to medical students at Wayne State
University, Detroit, Michigan, November 10, 2008.
"Rock the Match: strengthening your ERAS application” Talk to medical students at the regional Student
National Medical Association, Cleveland, Ohio, November 14, 2008.
"Rock the Match: strengthening your ERAS application” Talk to medical students at the national Student
National Medical Association, New Orleans, Louisiana, April 10, 2009.
“Rock the Match: How to beef up your application for Residency Programs.” Talk to medical students at
the national Latino Medical Student Association meeting in Chicago, Illinois, Mar 6, 2010
“Community Benefits: What does it mean?” Talk to the Minority Health Research Program’s Community
Advisory Board meeting in Ann Arbor, MI, Mar. 9, 2010.
“Rock the Match: How to beef up your application for Residency Programs.” Talk to medical students at
the Student National Medical Association meeting in Chicago, Illinois, April 2, 2010
“Diversity: Threading the Needle Between Federal Affirmative Action Mandates and State
Constitutional Amendments in Four States: Univ. of Michigan Medical School Experience. (panel
discussion) Assoc. of American Medical Colleges meeting, New Orleans, Louisiana, March 24, 2011.”
“Rock the Match: How to beef up your application for Residency Programs.” Talk to medical students at
the Latino Medical Student Association National Meeting at the Univ. of California, Irvine School of
Medicine (April, 3, 2011)
“Rock the Match: How to beef up your application for Residency Programs.” Talk to medical students at
the Student National Medical Association Meeting in Indianapolis, (April, 22, 2011)
Panelist for Kaplan Inc.’s, “Kaplan Live, Online Medical School Insider Event” (national/international
webcast featuring various premedical advisors and admissions related personnel). New York City, May 23,
2011.
Panelist for the Univ. of Michigan Staff Mentoring and Coaching for Diversity Conference (Ann Arbor,
MI), June 27, 2011.
“Medical School Curriculum.” Workshop for American Medical Student Association’s pre-medical
conference in Sacremento, CA (Oct 8-9, 2011)
“Rock the Match: How to beef up your application for Residency Programs.” Talk to medical students at
the central regional Student National Medical Association Meeting in Ann Arbor, (October, 22, 2011)
“Work hard to creatively address unmet needs and you will succeed.” Keynote talk for DNA Night
(program to engage Flint area high school students in medical genetics.) University of Michigan-Flint
December 20, 2011
“Manage your stress.” Keynote talk for Genesee Early College graduating class, University of MichiganFlint; May 19, 2013
12
13
COMMITTEE AND ADMINISTRATIVE SERVICE
University of Washington
1985-1991
1985-1991
1985-1991
Lecturer to Pathology Residents on Cardiovascular Pathology
Director, Autopsy Service, University Hospital, Seattle, WA
Director, Cardiovascular Pathology, University Hospital, Seattle, WA
University of Michigan
1992-present
1992-1998
1994-1997
1994-1997
1996-1997
2002-2011
2001-2011
2003-2011
2002-2011
2004-2008
2006-2008
Attending - autopsy service of Univ. Hospital
Univ. of Michigan Diversity Advisory Group
Assistant Dean for Faculty Affairs, University of Michigan, Ann Arbor, MI
Faculty Affairs Advisory Group
Medical School Dean Search Committee
Director of the Office of Diversity and Career Development, U. of M. Medical School
Medical School Executive Admissions Committee
University of Michigan Diversity Council (member)
Director, Minority Health Research Program, Univ. of Michigan School of Medicine.
Member, Planning Group for the Univ. of Michigan National Center for Institutional
Diversity.
Member, Univ. of Michigan Advisory Committee for the National Center for Institutional
Diversity-ADVANCE Project “Advancing Diversity and Excellence in Science and
Engineering.”
National
2001-2005
2001-2009
2009-2011
2008-2010
2009-2011
National Academy of Sciences Committee for “Assessment for NIH Minority Research
Training Programs Phase 3”
Member of the Association of American Medical Colleges Group on Student Affairs –
Minority Affairs Section (Univ. of Michigan representative).
Member of the Association of American Medical Colleges Group on Diversity and
Inclusion (Univ. of Michigan representative).
Association of American Medical Colleges Council of Deans Fellow
Member, Robert Wood Johnson Foundation Alumni Roundtable on Health and Health
Care
13
14
BIBLIOGRAPHY
Completed Publications in Scientific Journals:
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
Gordon D and Hove, MJ: Triplet excitons in the ionic radical salts of 2,3 dichloro-5, 6-dicyanobenzoquinone.
J. Chem. Phys;59:3419-3420, 1973.
Gordon D, Guyton, JR and Karnovsky, MJ: Intimal alterations in rat aorta induced by stressful stimuli. Lab.
Invest;45:14-27, 1981.
Comess, KA, Zibelli, LR, Gordon D and Frederickson, SR: Acute, severe, aortic regurgitation in Behcet's
syndrome. Ann. Int. Med;99:639-640, 1983.
Foy, HM, Maier, RV, Gordon D and Lee, MJ: Granulomatous peritonitis secondary to pinworm infection.
Infect. in Surg, pp.15-28; 1984.
Gown, AM, Vogel, AM, Gordon D and LU, PL: A smooth muscle-specific monoclonal antibody recognizes
smooth muscle actin isozymes. J. Cell Biol;100:807-813, 1985.
Owens, GK, Loeb, A, Gordon D and Thompson, MM: Expression of smooth muscle-specific alpha-isoactin in
cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J. Cell
Biol;102:343-352, 1986.
Gordon D, Mohai, LG and Schwartz, SM: Induction of polyploidy in cultures of neonatal rat aortic smooth
muscle cells. Circ. Res; 59:633-644, 1987.
Tsukada, T, Tippens, D, Gordon D, Ross, R and Gown AM: HHF35, a muscle-actin-specific monoclonal
antibody. I. Immunocytochemical and biochemical characterization. Am. J. Pathol; 126:51-60, 1987.
Gordon D, Schwartz SM: Replication of arterial smooth muscle cells in hypertension and atherosclerosis. Am.
J. Cardiol; 59(2): 44A-48A, 1987.
Reilly, DF, Gordon D, Schwartz, SM: Determination and comparison of the aortic polyploid smooth muscle
content of human hypertensive subjects and normotensive controls. Acta Physiologica Scandinavica;
133(Suppl. 571):181-188, 1988.
Wilcox, JN, Smith, K, Williams, LT, Schwartz, SM and Gordon D: Platelet-derived growth factor mRNA
detection in human atherosclerotic plaques, by in situ hybridization. J. Clin. Invest; 82:1134-1143, 1988.
Wilcox, JN, Smith, K, Schwartz, SM, Gordon D: Localization of tissue factor in the normal vessel wall and in
the atherosclerotic plaque. Proc. Natl. Acad. Sci. USA;86:2839-2843; l989.
Gordon D, Schwartz, SM, Benditt, EP and Wilcox, JN: Growth factors and cell proliferation in human
atherosclerosis. Transplantation Proceedings; 21(4):3692-3694, 1989.
Swedberg, SH, Brown, BG, Sigley, R, Wight, TN, Gordon D and Nicholls, SC: Intimal fibromuscular
hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients: Clinical, immunocytochemical,
light and electron microscopic assessment. Circulation; 80:1726-1736, 1989.
Allen, MD, Tsuboi, H, Togo, T, Eary, JF, Gordon D, Thomas, R and Reichenbach, DD: Detection of cardiac
allograft rejection and myocyte necrosis, by monoclonal antibody to cardiac myosin. Transplantation;
48(6):923-928, 1989.
Alpers, CE, Gordon D and Gown, AM: Immunophenotype of vascular rejection in renal transplants. Modern
Pathology; 3(2):198-203, 1989.
Gordon D, Reidy, MA, Benditt, EP and Schwartz, SM: Cell proliferation in human coronary arteries. Proc.
Natl. Acad. Sci; 87:4600-4604, 1990.
Kohler, T, Kirkman, TR, Gordon D and Clowes, AW: Mechanism of Long-Term Degeneration of Arterialized
Vein Grafts. Am. J. of Surg;160:257-261, 1990.
Goldman, ML, Whitley, MA, Gordon D, Shaw, DWW, Nicholls, SC, Wan, C and Nelson, JA: Yucatan
Microswine Model of Arteriosclerosis: Angiographic-Histologic Correlation. Seminars In Interventional
Radiology;7(2):80-85, 1990.
Gordon D and Schwartz, SM: Cell proliferation in human atherosclerosis.Trends in Cardiovascular
Medicine;1:24-28, 1991.
McKeown, PP, Tsuboi, H, Togo, T, Thomas, R, Tuck, R and Gordon D : Growth of tracheal anastomoses
using PDS or poly propylene sutures and continuous versus interrupted suturing techniques. Ann. Thor. Surg;
S1(4):636-641, 1991.
Allen, MD, Shoji, Y, Fujimura, Y, Eary JF, Gordon D, Thomas, R and Reichenbach, D: Effect of cyclosporine
on the uptake of monoclonal antibody to cardiac myosin. J. Heart Transplantation; 10:775-781, 1991.
14
15
23. Carlos, T, Gordon D, Fishbein, D, Himes, V, Coday, A, Ross, R and Allen, MD: Vascular cell adhesion
molecule-1 is induced on endothelium during acute rejection in human cardiac allografts. J. Heart and Lung
Transpl; 11:1103-1109, 1992.
24. McKeown, PP, Tsuboi, H, Togo, T, Thomas, R, Tuck, R and Gordon D: Growth of tracheal anastomoses using
PDS or poly propylene sutures and continuous versus interrupted suturing techniques. Ann. Thor. Surg;
51:636-641, 1991.
25. Nelken, N, Coughlin, S, Gordon D and Wilcox, JN: Monocyte chemoattractant protein-1 in human
atheromatous plaques. J. Clin. Invest., 1991;88:1121-1127.
26. Isik, FF, Ferguson, M, Yamanaka, E and Gordon D: Proliferating cell nuclear antigen: A marker for cell
proliferation in autopsy tissues. Arch. Pathol. Lab. Med; 116:1142-1146, 1992.
27. Gordon D: Growth factors and cell proliferation in human transplant arteriosclerosis. J. Heart Lung Transplant;
11(3 Pt 2): S7, 1992.
28. Isik FF, Valentine HA, McDonald TO, Baird A, Gordon D: Localization of bFGF in human transplant coronary
atherosclerosis. Ann. N. Y. Acad. of Sciences; 638:487-488, 1992.
29. Turka LA, Linsley PS, Lin H, Brady W, Leiden JM, Wei R, Gibson ML, Zheng X, Myrdal S, Gordon D,
Bailey T, Bolling SF, Thompson CB. T-cell activation by the CD28 ligand B7 is required for cardiac allograft
rejection in vivo. Proc. Natl. Acad. Sci. USA; 89:11102-11105, 1992.
30. O'Brien KD, Gordon D. Deeb S, Ferguson M, Chait A: Lipoprotein lipase is synthesized by macrophagederived foam cells in human coronary atherosclerotic plaques. J. Clin. Invest; 89:1544-1550, 1992.
31. Isik FF, McDonald TO, Ferguson M, Yamanaka E, Gordon D: Transplant arteriosclerosis in a rat aortic model.
Am. J. Pathol; 141:1139-1149, 1992.
32. Urieli-Shoval S; Meek RL; Hanson RH; Ferguson M; Gordon D; Benditt EP: Preservation of RNA for in situ
hybridization: Carnoy's versus formaldehyde fixation. J-Histochem-Cytochem; Dec; 40(12): 1879-85, 1992.
33. Huth M Gordon D Verrier ED Otto CM: Aortic valvular fibroma as a source of systemic emboli in POEMS
syndrome. J. Am. Soc. Echocardiogr;4(4):401-4, 1992.
34. Allen MD Shoji Y Fujimura Y Gordon D Thomas R Brockbank KG Disteche CM: Growth and cell
viability of aortic versus pulmonic homografts in the systemic circulation. Circulatio; 84(5 Suppl):III94-9, 1992.
35. Allen MD McDonald TO Carlos T Himes V Fishbein D Aziz S Gordon D Endothelial adhesion molecules
in heart transplantation. J Heart Lung Transplant; 11:S8-13, 1992.
36. Nabel EG, Gordon D, Yang Z, San H, Plautz GE, Gao X, Huang L, Nabel GJ: Gene transfer in vivo with DNALiposome Complexes: Lack of Autoimmunity and Gonadal Expression. Human Gene Therapy; 3:649-656,
1992.
37. Finta KM, Fischer MJ, Lee L, Gordon D, Pitt B, Webb RC: Ramipril prevents impaired endotheliumdependent relaxation in arteries from rabbits fed an atherogenic diet. Atherosclerosis; 100:149-156, 1993.
38. Nabel EG, Yanz Z, Liptay S, San H, Gordon D, Haudenschild CC, Nabel GJ: Recombinant platelet-derived
growth factor B gene expression in porcine arteries induces intimal hyperplasia in vivo. J. Clin. Invest; 91:18221829, 1993.
39. Nabel EG, Shum L, Pompili VJ, Yang ZY, San H, Shu HB, Liptay S, Gold L, Gordon D, Derynck R, Nabel
GJ: Direct gene transfer of transforming growth factor 1 into arteries stimulates fibrocellular hyperplasia.
Accepted to Proc. Natl. Acad. Sci. USA; 90:10759-10763, 1993.
40. Rekhter MD, Zhang K, Narayanan AS, Phan S, Schork MA, Gordon D: Type I collagen gene expression in
human atherosclerosis: Localization to specific plaque regions. Am. J. Pathol ;143:1634-1648, 1993.
41. O'Brien,E.R.; Alpers,C.E.; Stewart,D.K.; Ferguson,M.; Tran,N.; Gordon,D.; Benditt,E.P.; Hinohara,T.;
Simpson,J.B.; Schwartz,S.M. Proliferation in primary and restenotic coronary atherectomy tissue: Implications
for antiproliferative therapy Circ. Res; 73:223-231, 1993.
42. Nabel GJ, Nabel EG, Yang Z, Fox BA, Plautz GE, Gao X, Huang L, Shu S, Gordon D, Chang AE: Direct gene
transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in
humans. Proc. Natl. Acad. Sci. USA; 90:11307-11311, 1993.
43. San H, Yang Z, Pompili VJ, Jaffe ML, Plautz GE, Xu L, Felgner JH, Wheeler CJ, Felgner PL, Gao X, Huang L,
Gordon D, Nabel GJ, Nabel EG: Safety and short-term toxicity of a novel cationic lipid formulation for human
gene therapy. Human Gene Therapy; 4:781-788, 1993.
44. Beach KW, Hatsukami T, Detmer PR, Primozich JF, Ferguson MS, Gordon D, Alpers CE, Burns DH,
Thackray BD, Strandness DE. Carotid artery intraplaque hemorrhage and stenotic velocity. Stroke; 24:314319, 1993.
15
16
45. Aziz S, Tada Y, Gordon D, McDonald TO, Fareed J, Verrier ED: A reduction in accelerated graft coronary
disease and an improvement in cardiac allograft survival using low molecular weight heparin in combination
with cyclosporine. J.Heart Lung Transplant; 12(4):634-43, 1993.
46. Rekhter MD, Gordon D: Does platelet-derived growth factor-A chain stimulate proliferation of aterial
mesenchymal cells in human atherosclerotic plaques? Circ. Res; 75:410-417, 1994.
47. Rekhter, MD, Gordon D: Cell proliferation and collagen synthesis are two independent events in human
atherosclerotic plaques. J. Vasc. Res; 31:280-286, 1994.
48. O'Brien KD, Ferguson M, Gordon D, Deeb SS, Chait A: Lipoprotein lipase is produced by cardiac myocytes
rather than interstitial cells in human myocardium. Arterioscler. Thromb. 14:1445-1451, 1994.
49. Lin H, Bolling SF, Linsley PS, Wei RQ, Gordon D, Thompson CB, Turka LA: Long-term acceptance of
major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific
transfusion. J Exp Med; 178(5):1801-6, 1994.
50. Gibran NS, Isik FF, Heimbach DM, Gordon D: Basic fibroblast growth factor in the early human burn wound.
J. Surg. Res; 56:226-234, 1994.
51. Muller DWM, Gordon D, San H, Yang ZY, Pompili VJ, Nabel GJ, Nabel EG: Catheter-mediated pulmonary
vascular gene transfer and expression. Circ. Res; 75:1039-1049, 1994.
52. Muller DWM, Golomb G, Gordon D, Levy RJ: “Site-specific dexamethasone delivery for the prevention of
neointimal thickening after vascular stent implantation.” Coronary Artery Disease; 5:435-442, 1994.
53. Ohno T, Gordon D, San H, Pompili VJ, Imperiale MJ, Nabel GJ, Nabel EG: Inhibition of vascular smooth
muscle cell proliferation following arterial injury by genetic intervention. Science; 265:781-784, 1994.
54. Isik FF, Clowes AW, Gordon D: Elastin expression in a model of acute arterial graft rejection.
Transplantation; 58:1246-1251, 1994.
55. Wilcox JN, Nelken NA, Coughlin SR, Gordon D, Schall TJ: Local expression of inflammatory cytokines in
human atherosclerotic plaques. J. Atheroscler. Thromb; 1: S10-3, 1994.
56. Hatsukami TS, Thackray BD, Primozich JF, Ferguson MS, Burns DH, Beach KW, Detmer PR, Alpers C,
Gordon D, Strandness DE Jr: Echolucent regions in carotid plaque: preliminary analysis comparing threedimensional histologic reconstructions to sonographic findings. Ultrasound Med. Biol; 20(8):743-9, 1994.
57. Lin H, Wei RQ, Gordon D, Linsley P, Turka LA, Bolling SF: Review of CTLA4Ig use for allograft
immunosuppression. Transplant. Proc; 26(6):3200-1, 1994.
58. Plautz GE, Nabel EG, Fox B, Yang ZY, Jaffe M, Gordon D, Chang A, Nabel GJ: Direct gene transfer for the
understanding and treatment of human disease. Ann. N.Y. Acad. Sci; 716:144-53, 1994.
59. Rekhter MD, Gordon D: Active proliferation of different cell types, including lymphocytes in human
atherosclerotic plaques. Am. J. Pathol; 147:668-677, 1995.
60. Kolpakov V, Gordon D, Kulik TJ: Nitric oxide-generating compounds inhibit total protein and collagen
synthesis in cultured vascular smooth muscle cells. Circ. Res; 76:305-309, 1995.
61. Pompili VJ, Gordon D, San H, Yang Z, Muller DWM, Nabel GJ, Nabel EG: Expression and function of a
recombinant PDGF B gene in porcine arteries. Arterioscler. Thromb. Vasc. Biol; 15:2254-2264, 1995.
62. Kolpakov V, Rekhter MD, Gordon D, Wang WH, Kulik TJ: Effect of mechanical force on growth and matrix
protein synthesis in the in vitro pulmonary artery: Analysis of the role of individual cell types. Circ Res;
77:823-831, 1995.
63. Thackray BD, Burns DH, Fergurson MS, Gordon D, Beach KW, Hatsukami T, Detmer PR, Primozich JF,
Strandness DE. A new method of studying plaque morphology. Amer. J. of Cardiac Imaging; 9:149-156, 1995.
64. Kang S, Kim KJ, Griffiths CEM, Wong TY, Talwar HS, Fisher GJ, Gordon D, Hamilton TA, Ellis CN,
Voorhees JJ. Topical tretinoin (retinoic acid) improves early stretch marks. Arch Dermatol; 132:519-526,
1996.
65. Schwartz SM, Gordon D, Mosca RS, Bove EL, Heidelberger KP, Kulik TJ. Collagen content in normal,
pressure and pressure-volume overloaded developing human hearts. Am J Cardiol; 77:734-738, 1996.
66. Simari RD, San H, Rekhter M, Ohno T, Gordon D, Nabel GJ, Nabel EG. Regulation of cellular proliferation
and intimal formation following balloon injury in atherosclerotic rabbit arteries. J Clin Invest; 98:225-235,
1996.
67. Yang ZY, Simari RD, Perkins ND, San H, Gordon D, Nabel GJ, Nabel EG. Role of the p21 cyclin-dependent
kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc Natl Acad Sci USA;
93:7905-7910, 1996.
68. Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC. Nitric oxide reversibly inhibits the migration of
cultured vascular smooth muscle cells. Circ Res; 78:225-230, 1996.
16
17
69. Rekhter M, Nicholls S, Ferguson M, Gordon D. Cell proliferation in human arteriovenous fistulas used for
hemodialysis. Arteriosclerosis and Thrombosis; 13:609-617, 1996.
70. Nabel GJ, Yang ZY, Nabel EG, Bishop K, Marquet M, Felgner PL, Gordon D, Chang AE. Direct gene transfer
for treatment of human cancer. Ann. N.Y. Acad. Sci; 772:227-31, 1996
71. Chang MW, Ohno T, Gordon D, Lu MM, Nabel GJ, Nabel EG, Leiden JM. Adenovirus-mediated transfer of
the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima
formation following balloon angioplasty of the rat carotid artery. Mol. Med; 1(2):172-81, 1996.
72. Fox BA, Woffendin C, Yang ZY, San H, Ranga U, Gordon D, Osterholzer J, Nabel GJ: Genetic modification
of human peripheral blood lymphocytes with a transdominant negative form of Rev: safety and toxicity. Hum.
Gene Ther; 6(8):997-1004, 1995.
73. Rekhter MD, O'Brien E, Shah N, Schwartz SM, Si mpson JB, Gordon D: The importance of thrombus
organization and stellate cell phenotype in collagen I gene expression in human, coronary atherosclerotic and
restenotic lesions. Cardiovascular Research; 32:496-502, 1996.
74. Nabel GJ, Gordon D, Bishop DK, Nickoloff BJ, Yang ZY, Aruga A, Cameron MJ, Nabel EG, Chang AE.
Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex
gene with DNA-liposome complexes. Proc Natl Acad Sci USA; 93:15388-15393, 1996.
75. DeBruyne LA, Chang AE, Cameron MJ, Yang Z, Gordon D, Nabel EG, Nabel GJ, Bishop DK. Direct transfer
of a foreign MHC gene into human melanoma alters T cell receptor V beta usage by tumor-infiltrating
lymphocytes. Cancer Immunol. Immunother; 43(1): 49-58, 1996.
76. Welling TH, Davidson BL, Zelenock JA, Stanley JC, Gordon D, Roessler BJ, Messina LM. Systemic delivery
of the interleukin-1 receptor antagonist protein using a new strategy of direct adenoviral-mediated gene transfer
to skeletal muscle capillary endothelium in the isolated rat hindlimb. Hum. Gene Ther; 7(15):1795-802, 1996.
77. Stephan DJ, Yang ZY, San H, Simari RD, Wheeler CJ, Felgner PL, Gordon D, Nabel GJ, Nabel EG. A new
cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo. Hum. Gene Ther;
7(15):1803-12, 1996.
78. Isik FF, Coughlin SR, Nelken NA, Clowes AW, Gordon D. JE gene expression in an animal model of acute
arterial graft rejection. J. Surg. Res; 60(1):224-31, 1996.
79. Muller DW, Gordon D, Topol EJ, Levy RJ, Golomb G. Sustained-release local hirulog therapy decreases early
thrombosis but not neointimal thickening after arterial stenting. Am. Heart J; 131(2):211-8, 1996.
80. Sarkar R, Gordon D, Stanley JC, Web RC. Cell cycle effects of nitric oxide on vascular smooth muscle cells.
Am. J. Physiol. 272:10050-10057, 1997.
81. Sarkar R, Gordon D, Stanley JC, Webb RC. Dual cell cycle-specific mechanisms mediate the antimitogenic
effects of nitric oxide in vascular smooth muscle cells. J. Hypertens; 15(3):275-283, 1997.
82. Arai H, Gordon D, Nabel EG, Nabel GJ. Gene transfer of Fas ligand induces tumor regression in vivo. Proc.
Natl. Acad. Sci. USA; 94(25):13862-7, 1997.
83. Stephan D, San H, Gordon D, Nabel GJ, Nabel EG. [Gene transfer of interferon beta inhibits vascular smooth
muscle cell proliferation in vitro and in animal model of arterial injury.] Arch. Mal. Coeur. Vaiss; 90(8):1121-5,
1997.
84. Stephan D, San H, Yang ZY, Gordon D, Goelz S, Nabel GJ, Nabel EG. Inhibition of vascular smooth muscle
cell proliferation and intimal hyperplasia by gene transfer of beta-interferon. Mol. Med; 3(9):593-9, 1997.
85. Lin H, Gastman BR, Wei RQ, Kunkel SL, Gordon D, Bolling SF. Phase-directed therapy and cardiac
xenograft survival. J. Surg. Res; 72(1):84-8, 1997.
86. Jejurikar SS, Welling TH, Zelenock JA, Gordon D, Burkel WE, Carlson BM, Messina LM. Induction of
angiogenesis by lidocaine and basic fibroblast growth factor: a model for in vivo retroviral-mediated gene
therapy. J. Surg. Res; 67(2):137-46, 1997.
87. Hatsukami TS, Ferguson MS, Beach KW, Gordon D, Detmer P, Burns D, Alpers C, Strandness DE Jr. Carotid
plaque morphology and clinical events. Stroke; 28(1):95-100, 1997.
88. Lupinetti-FM; Kneebone JM, Rekhter MD, Brockbank KG, Gordon D. Procollagen production in fresh and
cryopreserved aortic valve grafts. J. Thorac. Cardiovasc. Surg; 113(1):102-7, 1997.
89. Tanner FC, Yang Z, Duckers E, Gordon D , Nabel GJ, Nabel EG: Expression of cyclin-dependent kinase
inhibitors in vascular disease. Circ. Res. 82:396-403, 1998.
90. Rekhter MD, Simari RD, Work C, Nabel EG, Gordon D. Gene transfer into normal and atherosclerotic human
blood vessels. Circ Res; 82:1243-1252, 1998.
91. Rekhter MD, Shah N, Simari RD, Work C, Kim J-S, Nabel GJ, Gordon D. Graft permeabilization facilitates
gene therapy of transplant arteriosclerosis in rabbit model. Circulation; 98(13): 1335-41, 1998.
17
18
92. Rekhter MD, Hicks GW, Brammer DW, Work CW, Kim JS, Gordon D, Keiser JA, Ryan MJ: Animal model
that mimics atherosclerotic plaque rupture. Circ Res, 83(7): 705-13, 1998.
93. Orekhov AN, Andreeva ER, Mikhailova IA, Gordon D: Cell proliferation in normal and atherosclerotic human
aorta: proliferative splash in lipid-rich lesions. Atherosclerosis; Jul; 139(1): 41-8, 1998.
94. Andreeva ER, Pugach IM, Gordon D, Orekhov AN: Continuous subendothelial network formed by pericytelike cells in human vascular bed. Tissue and Cell; Feb; 30(1): 127-35, 1998.
95. Ryan, MJ, Emig LL, Hicks GW, Ramharack R, Brammer DW, Gordon D, Auerbach BJ, Keiser JA: Influence
of lipoprotein(a) plasma concentration on neointimal growth in a monkey model of vascular injury.
Atherosclerosis 139:137-145, 1999.
96. Kornowski R, Leon MB, Fuchs S, Vodovotz Y, Flynn MA, Gordon D, Pierre A, Kovesdi I, Keiser JA, Epstein
SE: Electromagnetic-guidance for catheter-based trans-endocardial injection: a platform for intramyocardial
angiogenesis therapy. J. Am. Coll. Cardiol. 35(4):1031-1039, 2000.
97. Flynn MA, Vodovotz Y, Kornowski R, Epstein S, Gordon D, Keiser JA: Use of fluorescent microspheres to
localize in vivo gene transfer injection sites. BioTechniques, 28(3):470-476, 2000.
98. Song Y, Ford JW, Gordon D, Shanley CJ: Regulation of lysyl oxidase by interferon- in rat aortic smooth
muscle cells. Arterioscler. Thromb. Vasc. Biol. 20: 982-988, 2000.
99. Sjöland H, Eitzman DT, Gordon D, Westrick R, Nabel EG, Ginsburg D: Atherosclerosis progression in LDL
receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen
activator inhibitor-1. Arterioscler. Thromb. Vasc. Biol; 20(3):846-52, 2000.
100. Wang H, Gordon D, Olszewski B, Song YL, Kovesdi I, Keiser JA: Rat sponge implant model: A new system
for evaluating angiogenic gene transfer. Int. J. Mol. Med; 6(6):645-653, 2000.
101. Wang H. Liu C. Song Y. Gordon D. Alavi MZ. Moore S: Expression of metalloproteinases and its inhibitor
in later stage of rabbit neointima development. International Journal of Molecular Medicine. 7(1):105-12,
2001
102. Perrin LA, June JE, Rosebury W, Robertson A, Kovesdi I, Bruder JT, Kessler PD, Keiser, JA, Gordon D:
Increased revascularization efficacy after administration of an adenovirus encoding VEGF121. Gene Therapy
11:512-521, 2004.
103. Wang H, Keiser JA, Olszewski B, Brammer D, Gordon D: Dose-dependent neovascularization-promoting
effect of adenovirus vector CI-1023 in a rat hindlimb ischaemic model. Basic & Clinical Pharmacology &
Toxicology. 95(2):76-80, 2004 Aug
104. Wang H. Keiser JA. Olszewski B. Rosebury W. Robertson A. Kovesdi I. Gordon D: Delayed angiogenesis in
aging rats and therapeutic effect of adenoviral gene transfer of VEGF. International Journal of Molecular
Medicine. 13(4):581-7, 2004 Apr.
105. Miller DL, Li P, Gordon D, Armstrong, WF: Histological characterization of micro-lesions induced by
myocardial contrast echocardiography. Echocardiography 22(1):25-34, 2005.
106. Miller DL, Li P., Dou C., Gordon D., Edwards C. A. and Armstrong, W. F.: Influence of Contrast Agent Dose
and Ultrasound Exposure on Cardiomyocyte Injury Induced by Myocardial Contrast Echocardiography in Rats.
Radiology 2005;237:137-143
107. Shen Y, Bodary PF, Vargas FB, Homeister JW, Gordon D, Ostenso KA, Shayman JA, and Eitzman DT: Galactosidase A deficiency leads to increased tissue fibrin deposition and thrombosis in mice homozygous for
the Factor V Leiden mutation.” Stroke 2006 37: 1106 – 1108
108. Miller DL, Li P, Dou C, Armstrong WF, Gordon D. Evans blue staining of cardiomyocytes induced by
myocardial contrast echocardiography in rats: evidence for necrosis instead of apoptosis. Ultrasound Med Biol.
2007; 33(12):1988-96.
109. Gualano SK. Bolling SF. Gordon D. Wilson A. Bach DS.: High prevalence of false chordae tendinae in
patients without left ventricular tachycardia. Pacing & Clinical Electrophysiology, 2007, Suppl. 30, 1:S156-159
110. Hoashi T, Florentine MS, Gordon D, Ohye RG: Cardiac papillary fibroelastoma presenting as chorea in
childhood. Pediatr. Cardiol. 2009;30:995-7
111. Faust SM. Lu G, Marini BL, Zou W, Gordon D, Iwakura Y, Yasmina Laouar Y, and Bishop DK: Role of T
Cell Transforming Growth Factor Beta Signaling and IL-17 in Allograft Acceptancee and Fibrosis Associated
with Chronic Rejection" J. Immunol. 2009;183:7297-7306
112. Xu Z, Owens G, MD, Gordon D, Cain C, Ludomirsky A: Noninvasive creation of an atrial septal defect by
histotrypsy in a canine model. Circulation 2010, 121:742-749
113. Bhavsar J, Gordon D, Shea M: Listeria myocarditis with an atypical intracavitary vegetation/thrombus. Heart
2010, 96:1637. [case report]
18
19
114. Sean J English, Jose A Diaz, Xia Shao, David Gordon, Melissa Bevard, Gang Su, Peter K Henke, Virginia E
Rogers, Gilbert R Upchurch Jr and Morand Piert: Utility of 18F-FDG and 11C-PBR28 microPET for the
assessment of rat aortic aneurysm inflammation. EJNMMI Research (accepted for publication December 2013)
Chapters in Books and Invited Reviews
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
Gordon D and Schwartz, SM: “Arterial smooth muscle differentiation”, in: JH Campbell and GR Campbell
(eds.). In: Vascular Smooth Muscle in Tissue Culture, 1987.
Wilcox, JN, Schwartz, SM and Gordon D: “Local production of PDGF in the human atherosclerotic plaque”,
in: Habenicht, Springer-Verlag and Heidelberg (eds.), In: Growth Factors, Differentiation Factors and
Cytokines, 1990.
Gordon D: “Cell proliferation in human arteries”. Cardiovascular Pathology, 1992.
Nabel GJ, Nabel EG, Yang Z, Fox BA, Plautz GE, Gao X, Huang L, Shu S, Gordon D, Chang AE: “Molecular
genetic interventions for cancer.” Cold Spring Harbor Symposia on Quantitative Biology. Vol LIX:699-707,
1994.
Gordon D and Rekhter MD. “Cell proliferation and collagen gene expression in human intimal hyperplasia”.
In: Dorbin (ed), Intimal Hyperplasia, 1994.
Gordon D and Nable EG: “Growth factors as inducers of neointimal hyperplasia”. In: Orosz, Sedmak and
Ferguson (eds.), In: Transplant Vascular Sclerosis, 1995.
Kohler T and Gordon D. “Cerebrovascular atherosclerosis”. In: Zierler (ed), Surgical Management of
Cerebrovascular Disease, 1995.
Gordon D. “Pathology of Carotid artery restenosis”. In: Ernst and Stanley (eds), Current Therapy in Vascular
Surgery, 1995 edition (Elsevier).
Gordon D. “Transplant Arteriosclerosis”. In: Ross and Topol (eds). Atherosclerosis and Coronary Artery
Disease, 1996.
Gordon D., Rekhter MD: “The growth of human atherosclerosis: Cell proliferation and collagen synthesis.”
Cardiovasc. Pathol. 6:103-116, 1997.
Gordon D, Song Y: “The Pathology of Human Carotid Restenosis.” In Ernst and Stanley (eds), Current
Therapy in Vascular Surgery, 1999. (Elsevier)
Gordon D. “Transplant Arteriosclerosis” (Ch. 43, pp. 623-635) in Atherothrombosis and coronary Artery
Disease ed. Fuster, Topol, and Nabel. Copyright 2005 by Lippincott Williams & Wilkins.
Gordon D. “Pathology of Carotid artery restenosis”. In: Stanley, Veith & Wakefield (eds), Current Therapy in
Vascular and Endovascular Surgery, 2014 edition (Elsevier)
Abstracts, Preliminary Communication, Panel Discussions (not published in full)
1.
2.
3.
4.
5.
6.
7.
Gordon D, Vinter, D, Schwartz, SM and Gown, AM, Heterogeneity in the bovine aortic media. Fed. Proc.
45(3):683a,1986.
Gordon D, Kollman, GD and Reichenbach, DD, Smooth muscle actin heterogeneity and developing intimal
thickening in neonatal human coronary arteries. Fed. Proc., 1988.
Wilcox, JN, Augustine, AJ, Smith, KM, Schwartz, SM and Gordon D, Localization of cells expressing tPA,
PAII and urokinase by in situ hybridization in human atherosclerotic plaques and in the normal rhesus monkey.
Abstract International Thrombosis Meeting, Aug., 1989.
Gordon D, Reidy MA, Kollman G, Schwartz SM, Gown AM. Measures of cell proliferation in human coronary
and carotid arteries using cyclin/PCNA immunocytochemistry. FASEB J 1989;3:1318a.
Wilcox, JN, Schwartz, SM and Gordon D , Mesenchymal-appearing cells in the human saphenous vein
expressing tissue factor and PDGF receptor mRNAs may contribute to coronary bypass graft failure. 63rd
Scientific Sessions of the American Heart Association, Nov., 1990.
Wilcox, JN, Augustine, AJ, Schall, TJ and Gordon D, Local gene expression in human coronary arteries from
transplanted hearts analyzed by in situ hybridization. 63rd Scientific Sessions of the American Heart
Association, Nov., 1990.
Gordon D and Alpers, CE, Proliferation and growth factor expression in human transplant arteries. Presented
at the 1991 U.S. and Canadian Academy of Pathology Meeting, Chicago, Illinois.
19
20
8.
9.
10.
11.
12.
13.
14.
Isik FF, Coughlin SR, Clowes AW, Gordon D: JE gene expression in a animal model of transplant
arteriosclerosis. FASEB J. 1993. 7:A489.
Yang Z, Perkins ND, Simari RD, San H, Gordon D, Nabel GJ, Nabel EG. p21 cyclin-dependent kinase
inhibitor inhibits intimal lesions through cell cycle arrest and differentiation of vascular cells. Circulation, 68th
Scientific Session of the American Heart Association, Vol. 92, (2381) Oct., 1995.
Simari RD, San H, Ohno T, Gordon D, Nabel GJ, Nabel EG. Regulation of cellular proliferation and intimal
formation following balloon injury in hyperlipidemic rabbit arteries. Circulation, 68th Scientific Session of the
American Heart Association, Vol. 92, (2393) Oct., 1995.
Rekhter MD, Simari RD, Work C, Nabel EG, Gordon D. Adenovirus-mediated gene transfer into human
coronary arteries and rabbit aorta. Circulation, 68th Scientific Session of the American Heart Association, Vol.
92, (2397) Oct., 1995.
Shah N, Rekhter MD, Andreeva ER, Orekhov, AN. Fibrin is associated with arterial mesenchymal cell
proliferation in human aortas: implications for developments and progression of atherosclerosis. FASEB J.
(809) June 1996.
Wang H, Keiser JA, Olszewski B, Song Y, Rosebury W, Robertson A, Kovesdi I, Gordon D. The delayed
angiogenesis in aged rats can be accelerated by adenoviral gene transfer of VEGF. Circulation 100 (18): I-407,
Nov. 1999.
Bililolkar AN, Koelling TM, Aaronson KD, Dyke DBS, Gordon D, Matthews JC, Hummel SL, Wu AH.
Potential effect of grouping grades 1B with 1A in the revised ISHLT cardiac biopsy grading system. J Heart
Lung Transplant 2008;27:S243
Miscellaneous and Non Peer-Reviewed Publications:
1. Gordon, D: “Learn from Computer Industry.” In Modern Healthcare, March 16, 2010 (op-ed piece on making
healthcare cheaper).
Hobbies: Guitar playing, singing (including being a member of my temple’s choir), reading history/biographies,
computer strategy games. I have also finished the 10 mile Crim Walk four times.
[Revised, December 15, 2014]
20